HealthMediaNamaabout 5 hours ago
Honasa acquires 58% of Fluence Pharma, bets on Nutraceuticals push
4 min read
Honasa Consumer, parent of Mamaearth, acquired a 58% stake in Mumbai-based Fluence Pharma at an enterprise value of Rs 135 crore. The deal values Fluence at 3.4 times FY26 revenue and 15 times FY26 EBITDA. Honasa also formed a wholly owned subsidiary, Honasa Health Private Limited, to run the B2C nutraceuticals business separately.
Level
Hype check
Tap to vote and see what everyone thinks.
